Fundraising Fox

John Smither

Investor

Senior Advisor at Frazier Life Sciences · Chief Financial Officer at MBX Biosciences

Ventura County, California, United States

Find your path to John

293 people in our graph share verified history with John — schools, employers, funds. One of them is your warm intro.

Beth SeidenbergunlockedJohn: together at Amgen (2002–2005)
×9John: together at Amgen
×2John: together at Sienna Biopharmaceuticals

About

John W. Smither is an independent director and compensation committee chair at Genelux Corporation with a background in public accounting at Arthur Young (now Ernst & Young) and subsequent experience as Chief Financial Officer at several early-stage and biotech companies. Throughout his operating career, he oversaw capital formation, finance strategy, and FDA product launches while leading private and public financings exceeding $1.2 billion. He currently advises entrepreneurs and serves on multiple biotech company boards.

Chief Financial Officer at MBX Biosciences

Intro paths

→

In turn, John can intro founders to MBX Biosciences's investors below.

MBX Biosciences's investors · 5

Frazier Life SciencesPalo Alto · since 2022IU VenturesBloomingtonNew Enterprise Associates (NEA)Menlo Park · $200K – $40M checks · since 2020Norwest Venture PartnersMenlo Park · $10M – $30M checksOrbiMedNew York · $1M – $75M checks

Co-founders at MBX Biosciences

RDRichard DiMarchi
Richard DiMarchiExecutive Officer, Director
PK
Peter Kent HawrylukExecutive Officer, Director

Experience

  1. Genelux CorporationIndependent Director and Compensation Committee Chaircurrent2023 — presentGreater Los Angeles, California, United States
  2. New Amsterdam PharmaIndependent Director and Audit Committee Chaircurrent2023 — presentNetherlands
  3. eFFECTOR Therapeutics, Inc.Independent Director, Audit Committee Chair, Member of Nom and Gov Committee2018 — 2023
  4. Arcutis, Inc.Chief Financial Officer2019 — 2021Westlake Village, CA
  5. AchaogenIndependent Director, Audit Committee Chair and Member of the Compensation Committee2013 — 2020South San Francisco, CA
  6. Sienna BiopharmaceuticalsChief Financial Officer2018 — 2019Greater Los Angeles Area
  7. Kite PharmaInterim Chief Financial Officer2017 — 2018Santa Monica, CA
  8. UNITY BiotechnologyChief Financial Officer2016 — 2017Greater San Francisco Area
  9. Sienna BiopharmaceuticalsChief Financial Officer2016 — 2017Greater Los Angeles Area
  10. Kythera Biopharmaceuticals, Inc.Chief Financial Officer2007 — 2015Greater Los Angeles Area
  11. AmgenExecutive Director Finance, Accounting Operations2006 — 2007Greater Los Angeles Area
  12. AmgenExecutive Director Finance, Global ERP Program Office2005 — 2006Greater Los Angeles Area
  13. AmgenExecutive Director Finance, Commercial Business Analysis2004 — 2005Greater Los Angeles Area
  14. AmgenVice President Finance (CFO)2001 — 2004Lucerne Area, Switzerland
  15. AmgenDirector of Finance2000 — 2001Lucerne Area, Switzerland
  16. AmgenAssociate Director Finance, Research1999 — 2000Thousand Oaks, CA
  17. AmgenAssociate Director, Interim Head of Internal Audit1998 — 1999Thousand Oaks, CA
  18. DompéDirector2002 — 2004Milan Area, Italy
  19. Various Early Stage CompaniesCFO1991 — 1998Greater Los Angeles Area
  20. Ernst & YoungPartner1976 — 1991Greater Los Angeles Area

Skills & more

Start-ups33Finance49Accounting31Management23Analysis10Internal Audit11SEC filings13Sarbanes-Oxley Act10Financial Reporting12Financial Analysis9Due Diligence7Auditing2
+8 moreBiotechnologyAcquisition IntegrationMergers & AcquisitionsManagerial FinancePharmaceutical IndustryFinancial ModelingUS GAAPBusiness Strategy

From John's professional profile.

Colleagues at Frazier Life Sciences

Adam Simpson
Venture Partner at Frazier Life Sciences
Aditya Kohli
Partner at Frazier Life Sciences
Alan Frazier
Chairman Emeritus at Frazier Life Sciences
Albert Cha
Managing Partner at Frazier Life Sciences
Ali Jackson
Vice President and Counsel, Public Funds at Frazier Life Sciences
Amanda Wilson
Senior Tax Manager at Frazier Life Sciences
Angel Martin
Senior Associate at Frazier Life Sciences
Angie You
Senior Advisor at Frazier Life Sciences

Frequently asked questions

Who is John Smither?
John W. Smither is an independent director and compensation committee chair at Genelux Corporation with a background in public accounting at Arthur Young (now Ernst & Young) and subsequent experience as Chief Financial Officer at several early-stage and biotech companies. Throughout his operating career, he oversaw capital formation, finance strategy, and FDA product launches while leading private and public financings exceeding $1.2 billion. He currently advises entrepreneurs and serves on multiple biotech company boards.
Where does John Smither work?
John Smither is Senior Advisor at Frazier Life Sciences and Chief Financial Officer at MBX Biosciences.
Where did John Smither go to school?
John Smither studied at California State University, Los Angeles (BS, Accounting).

Same school

Also attended California State University, Los Angeles19

Emily DobroyExecutive Assistant at Mainsail PartnersJohn TracyFormer Chief Technology Officer of the Boeing Company at NEW VISTA CAPITALSimone YsaguirreClient Service Associate at Manhattan WestDeborah NguyenRed Tree Venture Labs Operating Partner at Red Tree VentureArthur JohnsonAdvisor at AUTHENTIC VENTURESTegan CramerExecutive Assistant at Shamrock Capital

+ 13 more

Shared employers

Also worked at Genelux Corporation2

Boris MinevInterim Chief Medical Officer at Calidi BiotherapeuticsThomas ZindrickExecutive Officer, Director at Genelux

Also worked at Arcutis, Inc.3

Patrick HeronManaging Partner at Frazier Life SciencesHarris WeberVice President at Bain Capital Life SciencesKeith LeonardExecutive Officer, Director at Unity Biotechnology

Also worked at UNITY Biotechnology6

Remi-Martin LabergeFounder and Chief Technology Officer at Arda TherapeuticsMichael SamarChief Financial Officer at Noema PharmaDan MarquessExecutive Officer at Unity BiotechnologyNathaniel E. DavidExecutive Officer, Director at Unity BiotechnologyTony W. LiangVP of Research/Co-Founder at PTM Therapeutics, Inc.Camille LandisChief Business Officer / Chief Financial Officer at T-Knife

Also worked at Amgen190

Parker ConradCo-founder & CEO of RipplingSeth LieblichInvestment Team at 8VCSean BruichChief Technology Officer at Flare Capital PartnersSteph ScottVice President at Questa CapitalBeth SeidenbergFounding Managing Director at Westlake Village BioPartnersKelli McKeirnanDirector of Administration at Westlake Village BioPartners

+ 184 more